CS Disco Up Over 20%, On Track for Largest Percent Increase Since August 2023 -- Data Talk
Dow Jones2026/11/04 16:01CS Disco, Inc. (LAW) is currently at $6.21, up $1.04 or 20.12%
--Would be highest close since Feb. 2, 2026, when it closed at $6.44
--On pace for largest percent increase since Aug. 10, 2023, when it rose 24.59%
--Currently up two consecutive days; up 20.58% over this period
--Best two day stretch since the two days ending March 3, 2026, when it rose 20.92%
--Down 19.97% year-to-date; on pace for worst year since 2024, when it fell 34.26%
--Down 90.57% from its all-time closing high of $65.88 on Sept. 8, 2021
--Down 0.16% from 52 weeks ago (Nov. 5, 2025), when it closed at $6.22
--Down 30.3% from its 52-week closing high of $8.91 on Dec. 11, 2025
--Up 125% from its 52-week closing low of $2.76 on Feb. 25, 2026
--Traded as high as $6.38; highest intraday level since Feb. 2, 2026, when it hit $6.52
--Up 23.5% at today's intraday high; largest intraday percent increase since Aug. 10, 2023, when it rose as much as 25.23%
All data as of 10:59:19 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 04, 2026 11:01 ET (16:01 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
